99 related articles for article (PubMed ID: 20561053)
1. Neuronal growth-inhibitory factor (metallothionein-3): evaluation of the biological function of growth-inhibitory factor in the injured and neurodegenerative brain.
Howells C; West AK; Chung RS
FEBS J; 2010 Jul; 277(14):2931-9. PubMed ID: 20561053
[TBL] [Abstract][Full Text] [Related]
2. Neuronal growth-inhibitory factor (metallothionein-3): reactivity and structure of metal-thiolate clusters.
Faller P
FEBS J; 2010 Jul; 277(14):2921-30. PubMed ID: 20561054
[TBL] [Abstract][Full Text] [Related]
3. Neuronal growth-inhibitory factor (metallothionein-3): a unique metalloprotein.
Huang ZX
FEBS J; 2010 Jul; 277(14):2911. PubMed ID: 20561056
[No Abstract] [Full Text] [Related]
4. Mammalian Metallothionein-3: New Functional and Structural Insights.
Vašák M; Meloni G
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28538697
[TBL] [Abstract][Full Text] [Related]
5. Neuronal growth-inhibitory factor (metallothionein-3): structure-function relationships.
Ding ZC; Ni FY; Huang ZX
FEBS J; 2010 Jul; 277(14):2912-20. PubMed ID: 20561055
[TBL] [Abstract][Full Text] [Related]
6. Use of proteomics for the identification of novel drug targets in brain diseases.
Morón JA; Devi LA
J Neurochem; 2007 Jul; 102(2):306-15. PubMed ID: 17419802
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein-I+II in neuroprotection.
Pedersen MØ; Jensen R; Pedersen DS; Skjolding AD; Hempel C; Maretty L; Penkowa M
Biofactors; 2009; 35(4):315-25. PubMed ID: 19655389
[TBL] [Abstract][Full Text] [Related]
8. Promoter-activated expression of nerve growth factor for treatment of neurodegenerative diseases.
Wyman T; Rohrer D; Kirigiti P; Nichols H; Pilcher K; Nilaver G; Machida C
Gene Ther; 1999 Oct; 6(10):1648-60. PubMed ID: 10516713
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a dynamic structure of human neuronal growth inhibitory factor and for major rearrangements of its metal-thiolate clusters.
Faller P; Hasler DW; Zerbe O; Klauser S; Winge DR; Vasák M
Biochemistry; 1999 Aug; 38(31):10158-67. PubMed ID: 10433724
[TBL] [Abstract][Full Text] [Related]
10. From angiogenesis to neuropathology.
Greenberg DA; Jin K
Nature; 2005 Dec; 438(7070):954-9. PubMed ID: 16355213
[TBL] [Abstract][Full Text] [Related]
11. Significance of metallothioneins in aging brain.
Sharma S; Ebadi M
Neurochem Int; 2014 Jan; 65():40-8. PubMed ID: 24389356
[TBL] [Abstract][Full Text] [Related]
12. Metal binding ability of metallothionein-3 expressed in Escherichia coli.
Toriumi S; Saito T; Hosokawa T; Takahashi Y; Numata T; Kurasaki M
Basic Clin Pharmacol Toxicol; 2005 Apr; 96(4):295-301. PubMed ID: 15755312
[TBL] [Abstract][Full Text] [Related]
13. The comparison of mouse full metallothionein-1 versus alpha and beta domains and metallothionein-1-to-3 mutation following traumatic brain injury reveals different biological motifs.
Manso Y; Serra M; Comes G; Giralt M; Carrasco J; Cols N; Vasák M; González-Duarte P; Hidalgo J
J Neurosci Res; 2010 Jun; 88(8):1708-18. PubMed ID: 20127815
[TBL] [Abstract][Full Text] [Related]
14. Sheep have an unusual variant of the brain-specific metallothionein, metallothionein-III.
Chung RS; Holloway AF; Eckhardt BL; Harris JA; Vickers JC; Chuah MI; West AK
Biochem J; 2002 Jul; 365(Pt 1):323-8. PubMed ID: 11931634
[TBL] [Abstract][Full Text] [Related]
15. Metallothionein I and II mitigate age-dependent secondary brain injury.
Natale JE; Knight JB; Cheng Y; Rome JE; Gallo V
J Neurosci Res; 2004 Nov; 78(3):303-14. PubMed ID: 15389833
[TBL] [Abstract][Full Text] [Related]
16. Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice.
Thompson SN; Gibson TR; Thompson BM; Deng Y; Hall ED
Exp Neurol; 2006 Sep; 201(1):253-65. PubMed ID: 16814284
[TBL] [Abstract][Full Text] [Related]
17. Distinct metal-thiolate clusters in the N-terminal domain of neuronal growth inhibitory factor.
Faller P; Vasák M
Biochemistry; 1997 Oct; 36(43):13341-8. PubMed ID: 9341226
[TBL] [Abstract][Full Text] [Related]
18. Metallothioneins in Prion- and Amyloid-Related Diseases.
Adam P; Křížková S; Heger Z; Babula P; Pekařík V; Vaculovičoá M; Gomes CM; Kizek R; Adam V
J Alzheimers Dis; 2016; 51(3):637-56. PubMed ID: 26923022
[TBL] [Abstract][Full Text] [Related]
19. Metal-thiolate clusters in the C-terminal domain of human neuronal growth inhibitory factor (GIF).
Hasler DW; Faller P; Vasák M
Biochemistry; 1998 Oct; 37(42):14966-73. PubMed ID: 9778374
[TBL] [Abstract][Full Text] [Related]
20. New insight into the molecular pathways of metallothionein-mediated neuroprotection and regeneration.
Chung RS; Hidalgo J; West AK
J Neurochem; 2008 Jan; 104(1):14-20. PubMed ID: 17986229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
